0001123292-17-001438.txt : 20170921
0001123292-17-001438.hdr.sgml : 20170921
20170921155343
ACCESSION NUMBER: 0001123292-17-001438
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170621
FILED AS OF DATE: 20170921
DATE AS OF CHANGE: 20170921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keefer Jason
CENTRAL INDEX KEY: 0001717590
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 171095812
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2017-06-21
0
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001717590
Keefer Jason
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
Interim President & CEO
Incentive Stock Option (right to buy)
16.24
2015-02-17
2025-02-17
Common Stock
15000
D
Incentive Stock Option (right to buy)
19.20
2016-09-21
2026-09-21
Common Stock
1000
D
3,750 shares underlying this option shall vest on each of February 17, 2015, February 17, 2016, February 17, 2017 and February 17, 2018, subject to Reporting Person's continued service through the applicable vesting date.
250 shares underlying this option shall vest on each of September 21, 2016, September 21, 2017, September 21, 2018 and September 21, 2019, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Jason Keefer
2017-09-21